Literature DB >> 2459703

Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteins.

V M Lee1, L Otvos, M L Schmidt, J Q Trojanowski.   

Abstract

Immunological and structural analyses of neurofilament (NF) proteins with greater than 500 anti-NF monoclonal antibodies (mAbs) enumerated epitopes shared by NF proteins and Alzheimer neurofibrillary tangles. We identified the multiphosphorylation domain of the rat heaviest NF subunit--tandem repeats of Lys-Ser-Pro-Xaa (where Xaa is a small uncharged amino acid and serine is phosphorylated)--as the determinant recognized by 15 of the 16 mAbs from this collection of greater than 500 mAbs that detected neurofibrillary tangles. Most (11) of these 16 mAbs also recognized the previously characterized multiphosphorylation repeat in the human middle sized NF subunit. However, although these mAbs shared the ability to recognize NFTs, the antigen-binding domains of these 16 mAbs represented 13 separate classes based on their differential recognition of 12 synthetic peptides derived from the rat heaviest NF subunit and the human middle-sized NF subunit multiphosphorylation sites, NF subunits of 10 diverse species, and normal human tau protein. We conclude that NFTs share highly specific immunological and structural properties with specific rat heaviest NF subunit and human middle-sized NF subunit multiphosphorylation repeats.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459703      PMCID: PMC282191          DOI: 10.1073/pnas.85.19.7384

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  An accurate and convenient organic phosphorus assay.

Authors:  C W McClare
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

2.  The structure, biochemical properties, and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state.

Authors:  M J Carden; W W Schlaepfer; V M Lee
Journal:  J Biol Chem       Date:  1985-08-15       Impact factor: 5.157

3.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

4.  Antibodies to neurofibrillary tangles of Alzheimer's disease raised from human and animal neurofilament fractions.

Authors:  P Gambetti; L Autilio-Gambetti; G Perry; G Shecket; R C Crane
Journal:  Lab Invest       Date:  1983-10       Impact factor: 5.662

5.  Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.

Authors:  G Perry; N Rizzuto; L Autilio-Gambetti; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Monoclonal antibodies recognize individual neurofilament triplet proteins.

Authors:  V Lee; H L Wu; W W Schlaepfer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

7.  Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles.

Authors:  K S Kosik; L K Duffy; M M Dowling; C Abraham; A McCluskey; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.

Authors:  D J Selkoe; C Abraham; Y Ihara
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

9.  Aberrant neurofilament phosphorylation in Alzheimer disease.

Authors:  N H Sternberger; L A Sternberger; J Ulrich
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it.

Authors:  J F Lees; P S Shneidman; S F Skuntz; M J Carden; R A Lazzarini
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  29 in total

1.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.

Authors:  I V Mersiyanova; A V Perepelov; A V Polyakov; V F Sitnikov; E L Dadali; R B Oparin; A N Petrin; O V Evgrafov
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

2.  alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.

Authors:  Nigel J Cairns; Kunihiro Uryu; Eileen H Bigio; Ian R A Mackenzie; Marla Gearing; Charles Duyckaerts; Hideaki Yokoo; Yoichi Nakazato; Evelyn Jaros; Robert H Perry; Steven E Arnold; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2004-05-28       Impact factor: 17.088

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.

Authors:  S E Arnold; V M Lee; R E Gur; J Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 5.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 6.  Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.

Authors:  Elvira Valera; Brian Spencer; Eliezer Masliah
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 7.  Tau function and dysfunction in neurons: its role in neurodegenerative disorders.

Authors:  Jesús Avila; Filip Lim; Francisco Moreno; Carlos Belmonte; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

8.  MSC p43 required for axonal development in motor neurons.

Authors:  Xiaodong Zhu; Yang Liu; Yanqing Yin; Aiyun Shao; Bo Zhang; Sunghoon Kim; Jiawei Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

9.  Molecular features of hypothalamic plaques in Alzheimer's disease.

Authors:  D G Standaert; V M Lee; B D Greenberg; D E Lowery; J Q Trojanowski
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

10.  Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells.

Authors:  M L Bush; J S Miyashiro; V M Ingram
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.